| K-number | DEN250013 |
| Device name | Modius Spero |
| Applicant | Neurovalens Limited |
| Product code | SHX |
| Device class | Class II |
| Decision date | May 8, 2026 |
| Decision | Not Substantially Equivalent |
| Regulation | — |
The FDA summary PDF for this submission is not available in machine-readable form — common for older clearances. View on FDA's site →
View the full FDA submission: accessdata.fda.gov